World / Arthritis
Early Diagnosis For Osteoarthritis
23.08.2008 10:18
medicalnewstoday.com
A newly developed medical imaging technology may provide doctors with a long-awaited test for early diagnosis of osteoarthritis (OA), scientists from New York reported at the 236th National Meeting of the American Chemical Society. By far the most common form of arthritis, OA is a bane of the Baby Boom generation, causing joint pain and disability for more than half of those over 65 - nearly 21 million people in the United States.
World
Arthritis
Discovery Of How Rheumatoid Arthritis Causes Bone Loss Holds Implications For Autoimmune Disease And Osteoporosis
23.08.2008 10:18
medicalnewstoday.com
Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.
World
Arthritis
Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate For Rheumatoid Arthritis
23.08.2008 10:18
medicalnewstoday.com
Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, today announced that it has acquired an oral, once-daily candidate for the treatment of rheumatoid arthritis (RA) which has completed a 160 patient, multi-center, double-blind, randomized, placebo-controlled Phase II clinical trial for the treatment of rheumatoid arthritis (RA).
World
Arthritis
Major Survey Shows Deficiency In Geriatric Care
23.08.2008 10:18
medicalnewstoday.com
In England, a large portion of the population is not receiving adequate basic care from the National Health Service and private healthcare systems, especially older and weaker people, according to a study released on August 15, 2008 in BMJ. As the populations in developed countries such as England become collectively older, health coverage issues for seniors and older adults are becoming increasingly important.
World
Arthritis
Scientists To Develop Rheumatoid Arthritis Vaccine
23.08.2008 10:18
medicalnewstoday.com
Scientists in the UK are hoping to develop a new vaccine using patients' own blood cells to suppress the effects of rheumatoid arthritis; if successful the work will signal a major breakthrough in the treatment of the auto-immune disease. Newcastle University's Musculoskeletal Research Group is to carry out the research, which is being funded by a 216,000 pound grant from the medical research charity the Arthritis Research Campaign.
World
Arthritis
Inflammation And Immunologic Symposium Explores New Research In Chronic Diseases
23.08.2008 10:18
medicalnewstoday.com
For the first time in the United States, more than 200 scientists from around the world will gather to explore research challenging conventional theories about immunology, inflammation and their link to acute and chronic diseases. The Damage Associated Molecular Pattern Molecules (DAMPs) and Alarmins Symposium will be held at the Hillman Cancer Center, 5115 Centre Ave., Pittsburgh, Aug. 30 through Sept. 2.
World
Arthritis
Mesoblast Limited Stem Cells Regrow Knee Cartilage In Severe Post-Menopausal Osteoarthritis
23.08.2008 10:17
medicalnewstoday.com
Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), announced successful preclinical trial results which showed that its proprietary adult stem cells regenerated and regrew damaged knee cartilage in post-menopausal osteoarthritis.
World
Arthritis
Key Clinical Studies Of Regeneron's ARCALYST (rilonacept) For Treatment Of CAPS Published
23.08.2008 10:17
medicalnewstoday.com
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced the publication of the results of three studies which supported the U.S. Food and Drug Administration (FDA) regulatory submission for ARCALYST® (rilonacept) Injection for Subcutaneous Use for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS). Two studies were published in the August 2008 issue of Arthritis and Rheumatism, the flagship publication of the American College of Rheumatology.
World
Arthritis
Low Vitamin D Levels Associated With Chronic Pain In Women
23.08.2008 10:17
medicalnewstoday.com
Low vitamin D levels may contribute to chronic pain among women, suggests research published ahead of print in the Annals of the Rheumatic Diseases. The findings are based on the blood analyses and pain scores of almost 7000 45 year old men and women from across England, Scotland and Wales, all of whom were born during one week in March 1958. Smokers, non-drinkers, the overweight and the underweight all reported higher rates of chronic pain.
World
Arthritis
B Cells Can Act Alone In Autoimmune Disease, Yale Researchers Report
23.08.2008 10:17
medicalnewstoday.com
B cells, the source of damaging autoantibodies, have long been thought to depend upon T cells for their activation and were not considered important in the initiation of autoimmune diseases like lupus or rheumatoid arthritis. In the Aug. 7 online issue of the journal of Immunity, Yale University researchers turn this paradigm on its head by showing that in systemic autoimmune diseases B cells can be activated the absence of T cells.
World
Arthritis
SCOLR Pharma, Inc. Submits Abbreviated New Drug Application For A 12-hour CDT-based Pseudoephedrine Formulation
23.08.2008 10:17
medicalnewstoday.com
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 89 percent of surveyed rheumatologists anticipate prescribing Roche/Chugai's Actemra, following the expected launch of the drug for rheumatoid arthritis in 2009.
World
Arthritis
Orthokine Treatment Is Effective For Knee Arthritis, Even After Two Years - Long-Study Confirms Effectiveness Of Autologous Therapy
23.08.2008 10:17
medicalnewstoday.com
The results of a two-year representative study of osteoarthritis of the knee, published in the internationally renowned journal "Osteoarthritis and Cartilage", confirm the safety and effectiveness of Orthokine therapy, in which anti inflammatory proteins obtained from the patient's own blood are injected into the arthritic joint.
World
Arthritis
Self-Repairing Cartilage? OHSU Research Reveals Important Clues
23.08.2008 10:17
medicalnewstoday.com
A strain of mice with the natural ability to repair damaged cartilage may one day lead to significant improvements in treatment of human knee, shoulder and hip injuries. Researchers at Oregon Health & Science University have discovered males from a strain of mice called MRL/MpJ have the innate ability to repair their own knee cartilage. "We think there is something special about these mice," said Jamie Fitzgerald, Ph.D.
World
Arthritis
FDA Advisory Committee Recommends Approval Of Actemra For The Treatment Of Rheumatoid Arthritis
23.08.2008 10:17
medicalnewstoday.com
Roche announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) by a near unanimous (10-1) vote recommended approval of Actemra (tocilizumab), a novel interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody, for reducing the signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA).
World
Arthritis
Frankincense Provides Relief To Arthritis Sufferers
23.08.2008 10:17
medicalnewstoday.com
An enriched extract of the 'Indian Frankincense' herb Boswellia serrata has been proven to reduce the symptoms of osteoarthritis. Research published in BioMed Central's open access journal Arthritis Research & Therapy has shown that patients taking the herbal remedy showed significant improvement in as little as seven days.
World
Arthritis
English